Every Form 4 that Omada Health, Inc. (OMDA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow OMDA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OMDA filings page.
Omada Health, Inc. (OMDA) reported that Chief Executive Officer and director Sean P. Duffy sold a total of 14,960 shares of common stock on September 10, 2026 in open-market transactions made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026. The filing also reports 851,659 shares of common stock held indirectly in family trusts for the benefit of his family members, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Omada Health, Inc. (OMDA) reported that its Chief Financial Officer, Steven L. Cook, sold a total of 6,800 shares of Common Stock on September 10, 2026, in open-market or private transactions under a Rule 10b5-1 trading plan adopted on March 14, 2026.
The sales consisted of 6,200 shares at a weighted average price of $21.80 (with individual trade prices between $21.38 and $22.35) and 600 shares at a weighted average price of $22.52 (with trade prices between $22.41 and $22.75). Post-transaction share holdings are not reported in this filing.
Omada Health, Inc. (OMDA) reported that President Wei-Li Shao sold a total of 4,036 shares of common stock on September 10, 2026. The sales were made in open market or private transactions at weighted average prices of $21.78 for 3,636 shares and $22.53 for 400 shares, pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026.
Omada Health, Inc. (OMDA) reported that its Chief Accounting Officer, Gracey Craig, sold 644 shares of common stock on September 9, 2026 at a weighted average price of $21.73 per share in an open-market or private transaction. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026, and left her with 14,412 shares of common stock held directly.
Omada Health, Inc. (OMDA) reported that President Wei-Li Shao had 1,843 shares of common stock disposed of on September 5, 2026 to pay the exercise price or related tax liability by delivering or having shares withheld at $22.77 per share. After this administrative disposition, Shao directly holds 299,349 shares of Omada Health common stock, and no Rule 10b5-1 trading plan is reported.
Omada Health, Inc. (OMDA) reported that its Chief Financial Officer, Steven L. Cook, had 2,010 shares of common stock disposed of on September 5, 2026 as a payment of exercise price or tax liability by delivering or withholding securities at a reference price of $22.77 per share. Following this transaction, he holds 180,706 common shares directly, and no Rule 10b5-1 trading plan is reported.
Omada Health, Inc. (OMDA) reported that Chief Executive Officer Sean P. Duffy had 4,422 shares of common stock delivered or withheld on September 5, 2026 to satisfy exercise price or tax liability at $22.77 per share. Following this transaction, he held 397,554 shares directly and 851,659 shares indirectly through family trusts, for which he disclaims beneficial ownership except to the extent of his pecuniary interest. No Rule 10b5-1 trading plan is reported.
Omada Health, Inc. (OMDA) reports that President Shao Wei-Li sold 9,418 shares of common stock on August 12, 2026 at $25.0167 per share in an open-market or private transaction made under a Rule 10b5-1 trading plan adopted on March 13, 2026. After this sale, Shao Wei-Li holds 307,372 shares directly. This amended Form 4 is filed solely to correct the number of shares sold, increasing it by 552 shares that were inadvertently omitted from the original report.
Omada Health, Inc. (OMDA) reported that its President, Wei-Li Shao, disposed of 6,180 shares of common stock on September 1, 2026 as shares were delivered or withheld for payment of exercise price or tax liability. After this transaction, he directly held 301,192 shares of Omada Health common stock.
Omada Health, Inc. (OMDA) reported that Chief Accounting Officer Gracey Craig had 385 shares of common stock withheld or delivered on September 1, 2026, as payment of exercise price or tax liability at $22.84 per share.
After this code F disposition, Craig holds 15,056 shares of Omada Health common stock directly. No Rule 10b5-1 trading plan is indicated for this transaction.
Omada Health, Inc. (OMDA) reported that Chief Financial Officer Steven L. Cook disposed of 4,493 shares of Common Stock on September 1, 2026. The shares were delivered or withheld as payment of exercise price or tax liability at $22.84 per share, leaving him with 182,716 shares held directly. No Rule 10b5-1 trading plan is reported.
Omada Health, Inc. (OMDA) reported that Chief Executive Officer and director Sean P. Duffy exercised previously vested stock options and sold shares on September 1, 2026 under a Rule 10b5-1 trading plan adopted on March 13, 2026. He exercised options covering 21,572 shares of common stock at exercise prices of $5.82, $8.28, and $9.18 per share, receiving an equal number of common shares. On the same date he sold a total of 21,572 shares of common stock in market transactions at weighted average prices between roughly $22.69 and $24.56 per share, and an additional 9,885 shares of common stock were delivered or withheld to cover the option exercise price or related tax liability. Following these transactions, an entity associated with him holds 851,659 shares of common stock indirectly through family trusts, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Omada Health, Inc. (OMDA) reported that its Chief Financial Officer, Steven L. Cook, exercised stock options and sold shares on August 27, 2026 under a Rule 10b5-1 trading plan adopted on March 14, 2026. He exercised options for 1,108 shares of common stock at an exercise price of $8.28 per share, then sold 1,108 common shares at $25.00 per share. The option grant was fully vested and exercisable, and following this exercise Cook held 233,481 stock options directly.
Omada Health, Inc. President Wei-Li Shao reported a sale of 8,866 shares of common stock on August 12, 2026 at $25.0167 per share in an open market or private transaction. The transaction was made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026, and left the reporting person with 307,372 shares held directly.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported option exercises and related share sales in mid-August 2026. He exercised stock options covering 16,842 shares of common stock at exercise prices between $7.68 and $8.28 per share and sold the same total number of shares at weighted average prices around $25 per share. The transactions were made pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2026, and include both fully vested options and options vesting monthly over four years.
Omada Health, Inc. insider Craig Gracey, Chief Accounting Officer, exercised stock options for 1,042 shares of common stock on August 10, 2026 at an exercise price of $6.57 per share. On the same date, 1,042 common shares were sold at $25.00 per share pursuant to a Rule 10b5-1 trading plan. Following the option exercise, 32,292 option shares remained outstanding and directly held.
Omada Health, Inc. chief executive officer Sean P. Duffy exercised stock options covering a total of 21,570 shares of common stock at exercise prices of $8.28 and $9.18 on August 7 and 10, 2026, and sold 21,570 shares, including a weighted-average sale at $24.8075, pursuant to a 10b5-1 trading plan adopted on March 13, 2026. The filing also reports 851,659 shares of common stock held indirectly in family trusts for his family members, with beneficial ownership disclaimed except for his pecuniary interest.
Omada Health, Inc. CEO Sean P. Duffy exercised stock options for 12,944 shares of common stock at $5.82 per share and on the same day sold 12,944 shares at a weighted average price of $20.3961 in open-market transactions between $20.15 and $20.58. The sale was executed under a Rule 10b5-1 trading plan adopted March 13, 2026. After the exercise, he held 142,483 options and 851,659 common shares indirectly through family trusts, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
HILLEMAN JERYL L reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. director Jeryl L. Hilleman received a grant of 1,435 restricted stock units of Common Stock on July 5, 2026 under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents one share, increasing her directly held beneficial ownership to 26,655 shares. This Form 4/A amends an earlier report that had understated both the RSU grant and resulting holdings due to an administrative error.
Omada Health, Inc. Chief Financial Officer Steven L. Cook exercised stock options for 12,150 shares of Common Stock at an exercise price of $8.28 per share, then sold 12,150 shares in open-market transactions at $24.0148 and $24.00 per share pursuant to a Rule 10b5-1 trading plan. Following these trades, he directly owned 187,209 shares of Common Stock.
Omada Health, Inc.'s Chief Accounting Officer, Gracey Craig, exercised stock options to acquire 1,041 shares of common stock at $6.57 per share and, on the same date, sold 1,041 shares in an open-market transaction at $24.00 per share pursuant to a 10b5-1 trading plan. Following these transactions, she holds 15,441 common shares directly and 33,334 stock options that remain outstanding.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported an exercise-and-sell transaction dated July 13, 2026. He exercised options for 5,800 common shares at $8.2800 per share and sold 5,800 common shares in open-market trades at $24.0100 and $24.0000 per share under a 10b5-1 trading plan, leaving 193,009 common shares held directly.
Omada Health, Inc.’s Chief Executive Officer Sean P. Duffy reported an amended insider transaction showing a series of same-day option exercises and open-market sales of common stock. Over June 24–26, 2026, he exercised options for 17,258 shares and sold 17,258 shares at prices around the high‑$19 to $20.90 range in pre-planned trades under a Rule 10b5-1 trading plan.
The amendment corrects the original Form 4 by adding the omitted exercise entries and adjusting the number of securities beneficially owned after the transactions. Following these sales, Duffy directly held 411,861 shares of Omada Health common stock, while family trusts held 851,659 additional shares for the benefit of his family members, for which he disclaims beneficial ownership except for his pecuniary interest.
Omada Health, Inc. Chief Accounting Officer Craig Gracey executed routine same-day option exercise-and-sale transactions and corrected prior reporting. On June 26, 2026 and June 29, 2026, Gracey exercised stock options at an exercise price of $6.57 per share and sold the resulting common shares in open-market transactions at prices of $20.00 and $21.00 per share. Following these transactions, Gracey directly beneficially owned 15,441 shares of common stock. The amended Form 4 restates an earlier filing to add the previously omitted option exercises and adjusts the reported beneficial ownership. The transactions were made under a Rule 10b5-1 trading plan adopted on March 13, 2026.
Omada Health’s Chief Accounting Officer Craig Gracey reported an amended insider transaction showing a same-day option exercise and share sale. Gracey exercised 2,083 shares of Common Stock through a stock option with a $6.57 exercise price, then sold 2,083 shares in an open-market transaction at a weighted average price of $19.0118 per share.
The amendment corrects a prior Form 4 that reported the sale but inadvertently omitted the exercise, which had understated shares beneficially owned after the trade. Following the correction, Gracey directly holds 15,441 shares of Common Stock and 39,584 stock options that are exercisable at $6.57 and expire on October 23, 2034. The sale was executed under a Rule 10b5-1 trading plan adopted on March 13, 2026.
Omada Health, Inc. Chief Accounting Officer Craig Gracey reported a corrected insider transaction reflecting a same-day option exercise and share sale. The amended filing adds an exercise of 2,083 shares of common stock at $6.57 per share and the corresponding sale of 2,083 shares at $18.00 per share. Following the sale, Gracey directly holds 15,441 shares of common stock and a stock option position showing 41,667 option shares outstanding. The transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026.
Omada Health, Inc. Chief Accounting Officer Craig Gracey filed an amended insider report detailing a same-day option exercise and share sale. Gracey exercised stock options to acquire 6,250 shares of common stock at $6.57 per share and sold 6,894 shares at a weighted average price of $17.4243 under a pre-arranged Rule 10b5-1 trading plan.
The amendment corrects an earlier filing that omitted the exercise leg of this exercise-and-sale transaction, which had caused reported post-transaction ownership to be understated. Following the transactions, Gracey directly holds 15,441 common shares and 43,750 stock options that remain outstanding.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported option exercises and matching share sales under a pre-arranged plan. On June 26 and June 29, he exercised stock options to acquire a total of 50,950 shares of common stock at exercise prices of $8.01 and $8.28 per share, then sold 50,950 shares in open-market transactions at weighted average prices of $19.8924 and $21.0678 per share. The filing states these were same-day exercise-and-sale transactions executed pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2026. After these transactions, Cook holds 187,209 shares of Omada Health common stock directly. This Form 4/A restates an earlier Form 4 to add previously omitted exercise transactions and correct the number of securities beneficially owned following the sales.
Omada Health, Inc.’s Chief Financial Officer Steven L. Cook reported a corrected set of insider transactions combining stock option exercises with same-day share sales. On June 24–25, 2026, he exercised options for a total of 2,900 shares of common stock at $8.01 per share and sold the same number of shares in open-market trades at weighted average prices of about $19.02 per share under a Rule 10b5-1 trading plan. Following these transactions, he directly held 187,209 shares of Omada Health common stock. This Form 4/A fully restates an earlier filing by adding the previously omitted option exercises and updating the post-transaction share balance that had been understated.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported an exercise-and-sale transaction and corrected prior share totals. On June 22, 2026, he sold 17,950 shares of common stock in an open-market transaction at a weighted average price of $18.1278 per share under a Rule 10b5-1 trading plan adopted on March 14, 2026.
On the same date, he exercised stock options to acquire 11,111 shares at an exercise price of $7.68 per share and 6,839 shares at an exercise price of $8.01 per share. Following these transactions, he directly holds 187,209 shares of common stock.
The amendment states the original Form 4 omitted the exercise transactions, which caused the previously reported amount of securities beneficially owned after the sales to be understated. This Form 4/A restates the filing to include the exercises and adjusts the post-transaction ownership figures accordingly.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported an exercise-and-sale transaction involving 35,600 shares of common stock. On July 1 and July 7, 2026, he exercised stock options covering 35,600 shares at exercise prices of $7.68, $8.01 and $8.28 per share and sold the same number of shares in open-market trades.
The reported sales were 23,263 shares at a weighted average price of $22.7615 per share and 12,337 shares at a weighted average price of $23.0883 per share. Following the transactions, Cook directly holds 187,209 shares of Omada Health common stock. The filing notes that at least one sale was made under a Rule 10b5-1 trading plan adopted on March 14, 2026.
FETTER TREVOR reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. director Trevor Fetter reported an equity compensation grant and an internal ownership transfer. He received 888 restricted stock units (RSUs) of Common Stock under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees, with each RSU representing one share to be settled under program terms.
Following this grant, Fetter directly holds 24,421 shares of Common Stock. Separately, 111,200 shares were transferred from a limited liability company to a family trust for which he serves as trustee and beneficiary, resulting in indirect ownership of those shares.
Omada Health, Inc. director Julie D. Klapstein reported receiving an equity grant of 649 shares of Common Stock in the form of restricted stock units. These RSUs were awarded at no cash cost per share under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees.
After this grant, Klapstein directly holds a total of 21,965 shares of Common Stock. The RSUs each represent the right to receive one share of Common Stock, with settlement occurring on a date selected by the director under the program or as otherwise provided by the plan. This is a routine, compensation-related acquisition rather than an open-market purchase.
HILLEMAN JERYL L reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. director Jeryl L. Hilleman received an equity award rather than making a market purchase. She was granted 1,299 restricted stock units under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents one share of common stock, to be settled on a future date as provided by the program. Following this grant, she holds 26,519 shares of Omada Health common stock directly.
ROOT JONATHAN D reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. director Jonathan D. Root received a grant of 820 restricted stock units as part of the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each unit represents one share of common stock, granted at no cash cost. Following this award, Root holds 191,877 shares of common stock directly, including the RSUs, with settlement to occur on a date selected under the program or as otherwise provided by that program.
Omada Health, Inc.’s Chief Executive Officer Sean P. Duffy reported an exercise-and-sell transaction in company stock. He exercised stock options for 12,942 shares at $8.28 per share and 12,944 shares at $5.82 per share, then sold 12,942 shares at a weighted average price of $22.6731 and 12,944 shares at $22.6968 in open-market trades. The sales were made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026. Following these transactions, he directly holds 411,861 shares of common stock and continues to hold stock options covering 116,077 and 155,427 shares at the respective exercise prices. In addition, 851,659 shares are held indirectly through family trusts for his family members, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Omada Health, Inc. Chief Accounting Officer Craig Gracey reported a small, pre-planned exercise-and-sell sequence in common stock. She exercised stock options to acquire 1,042 shares at $6.57 per share and sold 1,042 shares in open-market trades at $22.00 and $23.00 per share. After these transactions, she directly holds 15,441 common shares, so the sales represent roughly a mid–single-digit percentage of her holdings. The filing notes the trades were made under a Rule 10b5-1 trading plan adopted on March 13, 2026.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported a small, routine insider transaction involving company common stock. On June 30, 2026, he exercised stock options to acquire 300 shares at $8.28 per share and sold 300 shares in an open-market transaction at $22.00 per share. After these transactions, he directly held 115,409 shares of Omada Health common stock. A footnote states the sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2026, indicating the timing was planned in advance rather than a discretionary market-timing decision.
Omada Health, Inc. Chief Accounting Officer Craig Gracey reported two open-market sales of common stock. On June 26, 2026, she sold 2,084 shares at $20.00 per share, followed by 2,083 shares at $21.00 per share on June 29, 2026, for a total of 4,167 shares sold. These transactions were executed under a Rule 10b5-1 trading plan adopted on March 13, 2026. After the sales, she directly holds 858 shares of Omada Health common stock.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported selling a total of 50,950 shares of common stock in late June 2026. He executed open-market sales of 33,000 shares at an average price of $19.8924 on June 26 and 17,950 shares at an average price of $21.0678 on June 29. After these sales, he directly holds 115,409 Omada Health shares. One transaction was carried out under a Rule 10b5-1 trading plan that Cook adopted on March 14, 2026, indicating the sale was pre-arranged rather than timed discretionarily.
Omada Health, Inc. Chief Executive Officer Sean P. Duffy reported open-market sales of an aggregate 17,258 shares of Common Stock on June 24–26, 2026. The reported sale prices ranged from $19.0033 to $20.9000 per share.
After these transactions, Duffy directly holds 394,603 shares of Omada Health common stock. In addition, 851,659 shares are held in family trusts for the benefit of his family members, and he disclaims beneficial ownership of those shares except to the extent of his pecuniary interest. The filing notes that the sales were made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026.
Omada Health, Inc. Chief Accounting Officer Craig Gracey reported an open-market sale of common stock. On June 24, 2026, she sold 2,083 shares at a weighted average price of $19.0118 per share. The transaction was made under a Rule 10b5-1 trading plan adopted on March 13, 2026, and she now directly holds 5,025 shares of Omada Health common stock.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported open-market sales of 2,900 shares of common stock on June 24–25, 2026, at weighted average prices around $19 per share. The transactions were made under a pre-arranged Rule 10b5-1 trading plan. Cook directly holds 166,359 shares after these sales.
Omada Health, Inc. President Shao Wei-Li reported an amended open-market sale of 4,037 shares of Common Stock. The shares were sold on June 12, 2026 at a weighted average price of $17.2407 per share, leaving 316,790 shares beneficially owned afterward.
The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026. This Form 4/A corrects an earlier filing that had overstated the number of shares sold and the President’s resulting share ownership due to an administrative broker error.
Omada Health, Inc. Chief Financial Officer Steven L. Cook sold 17,950 shares of common stock in an open-market transaction at a weighted average price of $18.1278 per share. Following this sale, he directly holds 169,259 shares. The trade was made pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2026.
Omada Health, Inc. Chief Accounting Officer Craig Gracey reported an open-market sale of 2,083 shares of common stock at $18.0000 per share on June 22, 2026. After this transaction, Gracey directly holds 7,108 shares. The filing notes the trade was made under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026.
Omada Health, Inc. director Trevor Fetter reported an equity award and updated holdings. He received 10,882 shares of Common Stock as a grant, represented by restricted stock units (RSUs) with a grant price of $0.00 per share. Each RSU converts into one share upon vesting.
According to the footnotes, 100% of these RSUs will vest on the earlier of the first anniversary of the grant date or the date of the 2027 Annual Meeting of Omada Health stockholders, subject to his continued service. Following the award, he directly holds 23,533 shares and indirectly holds 111,200 shares through a family trust where he is a trustee and beneficiary.
Omada Health, Inc. director Jeryl L. Hilleman received an equity grant in the form of restricted stock units. The award covers 10,882 shares of Common Stock, with no cash paid per share. After this grant, Hilleman directly holds 25,220 shares.
The RSUs convert into one share of Common Stock each as they vest. According to the terms, 100% of the RSUs vest on the earlier of the first anniversary of the grant date or the date of the company’s 2027 Annual Meeting of stockholders, subject to continued service through that date.
Stavisky Adam reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. director Adam Stavisky reported receiving a grant of 10,882 restricted stock units (RSUs), each convertible into one share of Common Stock at no cost when vested.
All RSUs vest 100% on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting, subject to continued service, bringing his direct holdings to 20,618 shares.
Omada Health, Inc. director Jonathan D. Root received a grant of 10,882 restricted stock units, representing a stock-based compensation award with no cash purchase price. These RSUs convert into one share of common stock each upon vesting, with all units vesting on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of stockholders, subject to continued service. Following this grant, Root holds 191,057 shares of common stock.